Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex

Journal of Neuroimmunology

Volumn 54, Issue 1-2, 1994, Pages 59-68

  Xin, Zhicheng ^a,b   Tang, Hao ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Interleukin 2; Interleukin 4; Thymocyte; Vasoactive intestinal peptide

Indexed keywords

CALCIMYCIN; GLUCAGON; INTERLEUKIN 2; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; SECRETIN; T LYMPHOCYTE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ANIMAL; ANTIBODIES; ANTIGENS, CD3; CALCIMYCIN; CELL DIVISION; CYCLIC AMP; FEMALE; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, T-CELL; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; THYMUS GLAND; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0027942040     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(94)90231-3     Document Type: Article

References (60)

1. Developmental regulation of IL-4, IL-2 and IFNγ production by murine peripheral T lymphocytes
2. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels
3. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts
4. Inhibition of mouse T cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis
5. The thymic environment
6. The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature natural killer cells
7. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells
8. Developmental control of lymphokine gene expression in fetal thymocytes during T cell ontogeny
9. Cytokines in T cell development
10. − mouse thymocytes
11. Molecular basis for developmental changes in interleukin-2 gene inducibility
12. Distribution of neuropeptide Y, vasoactive intestinal peptide and somatostatin in populations of postganglionic neurons innervating the rat kidney, spleen and intestine
13. Murine thymocytes proliferate in direct response to interleukin-7
14. Specific binding sites for vasoactive intestinal peptide on nonadherent peripheral blood lymphocytes
15. − thymic T cell precursors differentiate in vitro into T cell receptor δ-bearing cells
16. Noradrenergic and peptidergic innervation of lymphoid tissue
17. High-affinity receptors for VIP on human myeloma cells
18. Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neurotransmission
19. Cytokine production by mature and immature thymocytes
20. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes
21. Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes
22. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus
23. Occurrence of vasoactive intestinal peptide (VIP) in lymphoid organs from rat and mouse
24. Interaction of vasoactive intestinal peptide with human blood mononuclear cells
25. Differentiation of thymocytes in fetal organ cultures: analysis of phenotypic changes accompanying the appearance of cytolytic and IL-2 producing cells
26. Generation and analysis of interleukin-4 deficient mice
27. Early precursor thymocytes can produce IL-2 upon stimulation with calcium ionophore and phorbol ester
28. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction
29. The neuroimmune link in the bronchus-associated lymphoid tissue (BALT) of cat and rat: peptides and neural markers
30. Modulation of T lymphocyte function by neuropeptides
31. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
32. Vasoactive intestinal polypeptide stimulation of adenylate cyclase in purified human leukocytes
33. Cyclic AMP-dependent protein kinase in MOLT 4B lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI)
34. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage
35. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.
36. Insertion and internalitation of vasoactive intestinal peptide receptors in murine CD4 T lymphocytes
37. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen response
38. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells
39. Vasoactive intestinal peptide-containing nerves in Peyer's patches
40. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptide and β-adrenergic agonist in murine T-cell lymphomas of immature, helper, and cytotoxic types
41. Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide
42. Development of functionally competent T cells
43. IL-2 gene inducibility in T cells before T cell receptor expression
44. Development in the thymus: it takes two to tango
45. Vasoactive intestinal peptide
46. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
47. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages
48. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages
49. Vasoactive intestinal peptide inhibits IL-2 and IL-4 production through different molecular mechanisms in T cells activated via the TCR/CD3 complex
50. Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide
51. Essential role of IL-2/IL-2R pathway in thymocyte maturation in vivo
52. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice
53. Interleukin-2 dependent autocrine proliferation in T cell development
54. Vasoactive Intestinal Peptide. Messenger in a Neuroimmune Axis
55. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells
56. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism
57. Binding of vasoactive intestinal peptide (VIP) by human blood monocytes: demonstration of specific binding sites
58. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts
59. Intrathymic radioresistant stem cells follow an IL-2/IL-2R pathway during thymic regeneration after sublethal irradiation
60. Are the IL-2 Receptors Expressed in the Murine Fetal Thymus Functional?